Aspen Aerogels (ASPN) Research & Development (2013 - 2026)

Aspen Aerogels has reported Research & Development for 14 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 37.13% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (down 34.02% YoY), and the FY2025 full-year result was $13.4 million, down 25.67% from the prior year.
• Research & Development for Q1 2026 stood at $2.7 million, down from $2.8 million in the prior quarter.
• The five-year high for Research & Development was $4.7 million in Q3 2022, with the low at $2.5 million in Q3 2025.
• Historically, Research & Development has averaged $4.0 million across 5 years, with a median of $4.2 million in 2022.
• Annual changes were most pronounced in 2022 — Research & Development soared 70.45% — and 2025, when it plunged 45.68%.
• Aspen Aerogels' Research & Development stood at $4.2 million in 2022, then declined by 2.91% to $4.1 million in 2023, then climbed by 8.1% to $4.4 million in 2024, then tumbled by 36.55% to $2.8 million in 2025, then dropped by 2.54% to $2.7 million in 2026.
• The last three Research & Development figures came in at $2.7 million (Q1 2026), $2.8 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.